This position paper describes a model for the future that would provide appropriate standardization, facilitate drug registration and support regulatory agencies.
The emerging markets represent an attractive investment opportunity for the pharmaceutical industry because of the countries' growing economies and unmet medical needs.
Quality-by-design risk assessment workflows can be laborious and have limited capacity to connect with vast volumes of prior knowledge generated by organizations. Their digital transformation can improve efficiency, reduce human errors, and facilitate integration within a much broader digital ecosystem.
In this final part of a series of three articles, the results from experiments involving cohesive materials are discussed in terms of mixing performance, agglomerate comminution, and lubrication of powder mixtures.
The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.
Regulatory, analytical, and process concerns must be taken into account.
This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
Challenges in fermentation can be addressed through equipment changes, facility design, and process development.
Was FDA's decision to issue a draft guidance on of-label information, amidst Congressional scrutiny, the right thing to do?
Needle-free injection technologies have been developed for injecting liquid formulations, as well as injecting drugs and vaccines in a solid dosage form.
The authors evaluated the effect of polymer composition on the drug-release profile and the effect of storage conditions on dissolution characteristics.
Kindeva’s microneedle array patch platforms for solid and liquid APIs have the potential to deliver far-reaching clinical, environmental, and usability benefits.
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Method-transfer kits help simplify analytical method transfer for global site certifications.
The authors describe the methods by which precise analyses of stable-isotopic abundances can be used in security and forensic applications for pharmaceutical materials. These methods include product and process authentication of raw materials, pharmaceutical intermediates, drug substances, formulated drug products, and synthetic pathways. Collectively, these methods can be used to investigate and mitigate patent infringement. In the future, more complete examples will be presented containing full isotopic results and the application of the methods described in this article.
Product variability from biopharmaceutical manufacturing to storage can significantly impact the safety and efficacy of batch-to-batch products during clinical use.
A fluorescence test method was used to visually evaluate handwashing efficacy. Difficult-to-clean areas on skin such as skin folds and webbing between fingers were identified; specific washing techniques to address problem areas are proposed.
BENEO produces galenIQ™, a water-soluble filler and binder. galenIQ™ has a sweetness and taste profile similar to sucrose, therefore it’s used to improve palatability of bitter-tasting active pharmaceutical ingredients and plant extracts.
Regulatory, analytical, and process concerns must be taken into account.
This article reviews a range of techniques available for separative analysis of mRNA therapeutics, their associated impurities, and delivery vehicles.
Predictive computational methods are finding wider use in pharmaceutical solid dosage development, particularly in mixing and blending, to improve tech transfer and equipment selection, and speed the acquisition of process understanding.
For drug sponsors that are considering building their own manufacturing facilities, an expert project team is crucial.
The authors review the current regulatory framework for the selection of drug substance starting materials.
Pharmaceutical Technology Europe spoke with experts about the developments that have shaped the nanotechnology industry today and the benefits that this technology has to offer the pharmaceutical industry, which remain largely untapped.
Webinar Date/Time: Wed, Oct 11, 2023 11:00 AM EDT
In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.
Despite pharmacovigilance legislation being in place for nearly a decade, many companies are still struggling to fulfill obligations.